RxDoctor Payments Data

Tara Louka, PA

Physician Assistant · Naples, FLNPI 1295710952

Payments from drug & device makers

$1,010in general payments, 2019–2025

Across 21 payments — averaging $48.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$205
  • Medtronic$181
  • AbbVie$125
  • E.r. Squibb & Sons, L.L.C.$110
  • Impulse Dynamics (USA) Inc.$85
  • Alnylam Pharmaceuticals Inc.$74
  • plus $231 from 8 others

What the payments were for

  • Food & beverage$1,010100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,010 in reported general payments places this provider in the 60th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$127,372
Medicare patients
793
Services billed
1,867

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban255$240,058
EntrestoSacubitril/Valsartan112$116,932
JardianceEmpagliflozin115$103,893
XareltoRivaroxaban62$77,978
Repatha SureclickEvolocumab60$47,942
FarxigaDapagliflozin Propanediol27$27,182
Praluent PenAlirocumab15$13,071
BrilintaTicagrelor18$9,706
Metoprolol Succinate423$6,456
Ezetimibe210$4,622
Rosuvastatin Calcium312$4,007
Valsartan68$1,977
Atorvastatin Calcium192$1,967
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide45$1,785
Diltiazem 24hr Er (Cd)Diltiazem Hcl64$1,578

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$18$240,058255 claims
NovartisEntresto$23$116,932112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Naples

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →